Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
GlobeNewswire
Sharps CEO issues letter to shareholders on FDA actions and tariffs affecting Chinese syringes.The FDA began raising quality..